A carregar...
Immediate‐release versus controlled‐release carbamazepine in the treatment of epilepsy
BACKGROUND: Carbamazepine (CBZ) is a commonly used drug for epilepsy that is associated with troublesome adverse events including dizziness, double vision, drowsiness, poor co‐ordination and unsteadiness. These adverse events often occur during peaks in drug plasma concentration. These adverse event...
Na minha lista:
| Publicado no: | Cochrane Database Syst Rev |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley & Sons, Ltd
2016
|
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6463840/ https://ncbi.nlm.nih.gov/pubmed/27933615 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD007124.pub5 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|